C9170 HCPCS Level II Code: Injection, tarlatamab-dlle, 1 mg
Medicare Coverage & Payment
- CMS short descriptor: Inj, tarlatamab-dlle, 1 mg
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Pricing indicator: 53
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2025
- Terminated: December 31, 2024
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Code Set: Removed from the code set — not valid on or after January 1, 2025.
Contextual Map
Every relationship of C9170 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- C9136 — Injection, factor viii, fc fusion protein, (recombinant), per i.u.[Sibling]
- C9137 — Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.[Sibling]
- C9138 — Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.[Sibling]
- C9139 — Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.[Sibling]
- C9140 — Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.[Sibling]
- C9141 — Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.[Sibling]
- C9142 — Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg[Sibling]
- C9143 — Cocaine hydrochloride nasal solution (numbrino), 1 mg[Sibling]
- and 32 more
Change history (2)
- January 1, 2025 — Removed from the code set [Change history]
- and 1 more
Sources for this page
Every coding fact on this page is read from the datasets below. Nothing is AI-generated; MedCoder-derived relationships and editorial are labelled where they appear.
- Code, descriptors, coverage and pricing attributes
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update
- Change history and date-of-service validity
- CMS HCPCS quarterly update files, ingested into the change ledger
- Comparisons, relationships and the contextual map MedCoder-derived
- Derived by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
Change history
- January 1, 2025Removed from the code setInjection, tarlatamab-dlle, 1 mg
- October 1, 2024Added to the code setInjection, tarlatamab-dlle, 1 mg
Nearest Codes in This Family
Official HCPCS Level II classifications closest to C9170 in its code family, with their registry titles.
- C9165 — Injection, elranatamab-bcmm, 1 mg
- C9166 — Injection, secukinumab, intravenous, 1 mg
- C9167 — Injection, adamts13, recombinant-krhn, 10 iu
- C9168 — Injection, mirikizumab-mrkz, 1 mg
- C9169 — Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- C9171 — Injection, pegulicianine, 1 mg
- C9172 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- C9173 — Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- C9174 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- C9175 — Injection, treosulfan, 50 mg